Company: PACB
Filing Date: 2025-06-06
Form Type: 8-K
Source: 0001299130-25-000140
Chunk: 0

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-06-06
Form: 8-K
Item: Item 5.02
Chunk 0
---
ITEM 5.02. DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.

On April 22, 2025, the board of directors (the "Board") of Pacific Biosciences of California, Inc. (the “ Company”), at the recommendation of the compensation committee of the Board, approved an amendment (the “ Amendment”) to the Company’s 2020 Equity Incentive Plan (the “2020 Plan”), subject to stockholder approval, to reserve an additional 23,000,000 shares of the Company’s common stock (the “ Additional Shares”) for issuance pursuant to the 2020 Plan. As described below under Item 5.07, the stockholders of the Company approved the Amendment at the annual meeting of stockholders held virtually on June 4, 2025 (the “ Annual Meeting”).

A more complete description of the material terms of the Amendment and 2020 Plan can be found in “ Proposal 4: Approval of Amendment to the 2020 Equity Incentive Plan” in the Company’s definitive proxy statement originally filed with the Securities and Exchange Commission (“ SEC”) on April 23, 2025 (as supplemented, the “ Proxy Statement”), which description is incorporated by reference herein. The foregoing descriptions and the descriptions incorporated by reference from the Proxy Statement are qualified by reference to the full text of the 2020 Plan, as amended, a copy of which is filed as Exhibit 10.1 to this report and incorporated by reference herein.